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The Clearview Chlamydia test (CV; Unipath Ltd., Bedford, United Kingdom), the Magic Lite Chlamydia
test (ML; CIBA Corning, Medfield, Mass.), a polymerase chain reaction (PCR), and cell culture (CC) were
evaluated for detection of Chlamydia trachomatis in urogenital specimens. Specimens were collected from 283
men and 724 women visiting the outpatient clinic for Sexually Transmitted Diseases at the University Hospital
Rotterdam, Rotterdam, The Netherlands. ML, PCR, and CC were all performed on the same sample to
prevent swab-to-swab variability. CV was performed on a separate sample. Analysis of discordant results was
performed by application of the following confirmatory assays: first, PCR on the CC, second, ML was
repeated, and third, PCR was repeated by using a different DNA extraction protocol. If more than one test was
positive, the sample was considered true positive. If only one test was positive, which was confirmed by the
confirmatory assay, the sample was also considered true positive. By using these interpretations, the following
results were obtained. The sensitivity and specificity of CV for samples from men were 60.4 and 86.3%,
respectively. For samples from women, these values were 62.3 and 99.7%, respectively. The low specificity for
samples from men was caused by unidentified substances in the swab that was used. The use of CV on samples
from men is not recommended by the manufacturer. For samples from women, the specificity of CV was high,
but the low sensitivity of CV limits its use for diagnostic purposes. The sensitivities ofML were low for samples
from both men and women (68.8 and 50.9%o respectively), while specificities were excellent for samples from
both groups (100 and 99.9%o, respectively). The low sensitivity of ML limits its diagnostic value. The PCR
technique was highly specific for samples from both men (99.6%) and women (99.9%o). The sensitivity of PCR,
however, was unexpectedly low for samples from both groups (men, 87.5%; women, 79.2%), most likely
because of the sample treatment method used. The sensitivity and specificity values ofCC for samples from men
were 95.8 and 100%, respectively. For samples from women, these values were 100 and 99.9%o, respectively.
In the present study, CC was the most reliable technique for the detection of C. trachomatis.
Chlamydia trachomatis is now the most common report-
able sexually transmitted disease. Approximately 4 million
cases occur annually in the United States (4). The clinical
spectrum of the disease ranges from urethritis, cervicitis,
and endometritis to salpingitis and perihepatitis (21). Chla-
mydial infections often are asymptomatic or nonspecific in
their clinical course. This lack of evident symptoms contrib-
utes to the further spread of the disease. Moreover, salpin-
gitis caused by C. trachomatis, although often asymptom-
atic, is a frequent cause of infertility in women (4). The
optimal antibiotic therapy for chlamydial infections is doxy-
cycline or erythromycin. Because of the serious sequelae,
the lack of specific signs and symptoms, and the specific
therapy required, it is important to have a reliable diagnostic
test.
The diagnosis of chlamydial infections is mainly based on
culture of the organism on HeLa 229 or McCoy cells, which
takes several days and requires extensive laboratory facili-
ties. In addition, circumstances with regard to transport and
storage of the sample may influence the reliability of the cell
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culture result considerably (12, 13). The availability of new
antigen detection techniques has overcome these disadvan-
tages. At first, a direct fluorescent-antibody test was devel-
oped; this was soon followed by several enzyme immunoas-
says. Both direct fluorescent-antibody tests and enzyme
immunoassays have been compared with cell culture and
with each other in a number of studies. The results of those
studies are summarized and discussed in three reviews (2, 7,
21).
Recently, tests based on the recognition of specific DNA
or RNA sequences have been developed. A nonisotopic
DNA probe for the detection of C. trachomatis in urogenital
specimens is commercially available and has been compared
with cell culture, direct fluorescent-antibody test, and poly-
merase chain reaction (PCR) as a reference (9, 10, 14, 27).
Also, several PCRs have been described and evaluated
previously (3, 5, 6, 16, 17).
In the present study, we evaluated three recently devel-
oped alternatives to cell culture. The Clearview Chlamydia
test (CV; Unipath Ltd., Bedford, United Kingdom) is a
rapid, solid-phase sandwich immunoassay which requires
minimal laboratory facilities and hands-on time. According
to the manufacturer, CV is recommended for testing only
female cervical samples. The Magic Lite Chlamydia test
(ML; CIBA Corning, Medfield, Mass.) is a new chemilumi-
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nometric sandwich immunoassay. This test is easy to per-
form and can be fully automated. The PCR used in the
present study is a modification of the method we evaluated
and described before (6, 10). Instead of the laborious phenol
extraction method that we used previously, a simplified
sample preparation procedure was applied. These modifica-
tions should make the PCR suitable for processing large
numbers of specimens in routine settings.
CV, ML, and PCR were initially compared with cell
culture (CC) as the "gold standard." Thereafter, analysis of
discordant results was performed by using the following
confirmatory assays: (i) PCR on the CC, (ii) repreat ML, and
(iii) repeat PCR by using a different DNA extraction proto-
col. If more than one test was positive, the sample was
considered true positive. If only one test was positive and
this positive result was confirmed by the confirmatory assay,
the sample was also considered true positive. In this way we
could evaluate possible failures of CC and thus improve the
value of the present evaluation.
MATERIALS AND METHODS
Patients and specimens. Specimens were collected from
283 men and 724 women visiting the outpatient clinic for
Sexually Transmitted Diseases at the University Hospital
Rotterdam. Male urethral and female cervical samples were
collected. To eliminate swab-to-swab variability, ML, PCR,
and CC were performed on the same sample. This sample
was taken by using a dacron E.N.T. swab (Medical Wire and
Equipment Co., Corsham, Willshire, United Kingdom),
which was placed into 2 ml of 0.2 M sucrose phosphate
buffer (2-SP). The portion for CC was stored at 4°C or, when
not tested within 24 h after collection, at -70°C. All CCs
were performed within 7 days. In a previous study, these
transport conditions have been shown to give optimal sen-
sitivity (24). The portion of the sample used for ML was
stored at 4°C or, when not tested within 5 days after
collection, at -20°C. All samples for ML were processed
within 14 days. This procedure was approved by the manu-
facturer. The 2-SP portion for PCR was stored at -70°C, and
all samples for PCR were processed within 7 days. In a pilot
study, it was shown that the 2-SP transport medium caused
both false-negative and false-positive results in the CV.
Therefore, the CV was performed on a separate sample. The
female samples for CV were collected by using the swab
provided by the manufacturer (Unipath Ltd.). This swab was
not appropriate for taking male urethral samples. To obtain
samples from males, a dacron E.N.T. swab with an alumi-
num shaft (Medical Wire and Equipment Co.) was used. The
swab was transported to the laboratory, where the samples
were stored at 4°C until testing. All tests were performed
within 3 days. During the first 3 months of the study, the
sample for CV was taken before the 2-SP sample. The
sampling order was reversed during the second part of the
study. The remainder of the 2-SP sample was stored at
-70°C for further reference.
CC. McCoy cells were grown as monolayers in plastic
culture flasks (no. 3150; Costar, Cambridge, Mass.). Com-
plete medium I for cell growth and maintenance consisted of
Eagle minimal essential medium (Autopow; Flow Laborato-
ries, Inc., Irvine, Scotland) containing 10% (vol/vol) fetal
bovine serum (Hyclone Laboratories, Inc., Logan, Utah),
1% (vol/vol) vitamins (10Ox vitamins for Eagle minimal
essential medium; Flow), 1% (vol/vol) glutamine (L-glu-
tamine [200 mM] for cell culture, 29.23 mg/ml; Flow),
gentamicin (20 ,ug/ml), amphotericin B (5 i±g/ml), and
NaHCO3 (2.0 g/liter [pH 7.5]). For chlamydial growth,
complete medium II was used; this medium contained van-
comycin (25 ,ug/ml), glucose (4.5 g/liter), and cycloheximide
(1 ,ug/ml) (Sigma Chemical Co., St. Louis, Mo.).
McCoy cells were suspended to a concentration of 3.5 x
105/ml, of which 200 ,ul was passed to a microdilution plate
containing 96 wells (Falcon 3070; Becton Dickinson Lab-
ware, Oxnard, Calif.). The plates were incubated overnight
at 37°C in a humidified atmosphere of 5% CO2. Before
inoculation of the specimen, the cell monolayer was in-
spected for confluency and was rinsed twice with 100 ,u of
complete medium II. A total of 45 specimens and 3 controls
were cultured in duplicate in the 96-well microtiter plate. All
three controls were positive controls, containing a mixture
of C. trachomatis serotypes D, E, F, H, and K. These five
serotypes are responsible for approximately 90% of the
infections caused by C. trachomatis in Rotterdam (25). After
the specimens and controls were agitated (SMI multitube
vortexer; American Hospital Supply Corp., Miami, Fla.) for
30 s (speed 5), 200 ,ul was added to each of two wells
containing McCoy cell monolayers. The inoculum was cen-
trifuged onto the cells at 1,400 x g for 60 min, after which the
fluid was replaced with 100 RI of complete medium II. After
48 h of incubation at 37°C in a humidified atmosphere of 5%
CO2, the monolayers were fixed with ethanol (96%) for 10
min and stained with fluorescent monoclonal Chlamydia
anti-major outer membrane protein antibodies (Microtrak;
Syva Co., Palo Alto, Calif.). The plates were viewed with a
Leitz fluorescent microscope at a magnification of x201.6
and were examined for inclusions. Culture results were
scored as follows: 0, no inclusion per two wells; 1, 1 to 5
inclusions per well; 2, 6 to 20 inclusions per well; and 3, >20
inclusions per well. The inoculated CC plates were stored at
-200C.
CV. CV was performed according to the manufacturer's
instructions for females. A different swab was used for
males. Tests were performed twice a week, and one positive
control was included in each run. Upon testing, the swabs
were placed into a flexible reaction tube containing 0.6 ml of
extraction buffer and were vortexed. The tube containing the
swab was then placed into a heating block at 80°C for 10 min.
After cooling for 5 min at room temperature, the swab was
rotated in the buffer and was removed from the tube. Five
drops (+±150 p,l) of the mixture was added to the absorbant
pad in the sample window of a small immunochromato-
graphic device. The part of the absorbant pad in the sample
window contains dried, colored latex particles coated with
monoclonal antibodies to chlamydial antigen. The absorbant
pad is in contact with a membrane strip to which two lines of
antibodies have been immobilized. The first immobilized
line, the result window line, contains monoclonal antibodies
to chlamydial antigen. The second line, the control window
line, contains polyclonal antibodies to mouse immunoglob-
ulin. If chlamydial antigen is present in the sample, it will
react with the antibody bound to the latex particles, forming
a complex. This complex is carried up to the immobilized
monoclonal antibodies to chlamydial antigen, where the
complex is captured, to form a sandwich. This gives a line in
the result window. If chlamydial antigen is not present in the
sample, no sandwich is built up and the result window
remains clear. In either case some latex particles are carried
on to the immobilized line of antibodies to mouse immuno-
globulin, forming a line in the control window. If the control
window remained clear, the sample was considered not
evaluable.
ML. The swab and transport medium for ML were differ-
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ent from those in the officially recommended system. Al-
though the manufacturer approved the use of the system, it
may have influenced the results. Furthermore, the procedure
was performed exactly according to the manufacturers'
instructions. In each run, one positive and one negative
control were included. The negative control was determined
in triplicate, and the positive control and the patient samples
were determined in duplicate. Two hundred microliters of
sample was added to 750 ,ul of reagent buffer, and the
mixture was vortexed twice for 15 s. Two hundred microli-
ters of this pretreated sample was added to the reaction tube.
Then, 100 ,ul of reaction buffer was added and the sample
was vortexed. Subsequently, 100 tl of monoclonal anti-
Chlamydia antibody labeled with an acridinium ester was
added; this was followed by the addition of 500 ,u of
polyclonal anti-Chlamydia antibody covalently bound to
paramagnetic particles. The mixture was vortexed and incu-
bated at room temperature for 90 min. After incubation, the
tubes were placed on the magnetic separation base for 3 min.
The supernatants were decanted and the tubes were blotted
while holding the tube rack and the base of the magnetic
separation unit together. One milliliter of wash buffer was
added, and after vortexing, the magnetic separation proce-
dure was repeated. Finally, 100 ,u of distilled water was
added and the results were read with a luminometer (Magic-
Lite Analyzer). The results were given as relative light units
(RLUs). Interpretations were made by using two cutoff
factors (1.6 and 2.3), which were recommended by the
manufacturer. If the mean value of the duplicate determina-
tion (test result) was <1.6 times the mean of the negative
control, the sample was considered negative. If the test
result was >2.3 times the mean of the negative control, the
sample was considered positive. Finally, if the test result
was 21.6 times and c2.3 times the mean of the negative
control, the sample was retested by a blocking assay. The
blocking assay used a monoclonal anti-Chlamydia antibody
with an epitope different from those of the monoclonal and
polyclonal anti-Chlamydia antibodies used in the routine
assay. Pretreatment of the sample was identical to that
described above. After the reaction buffer was added, 100 ,ul
of blocking agent was added, and the mixture was vortexed
and incubated for 30 min at room temperature. Subse-
quently, the routine procedure was followed starting with
the addition of the acridinium ester labeled monoclonal
anti-Chlamydia antibody. Interpretations were made by us-
ing the following calculation:X = (A/B) x (CID), whereA is
the RLUs of the negative control in the assay of the blocked
sample, B is the RLUs of the negative control in the assay of
the unblocked sample, C is the RLUs of the unblocked
sample, and D is the RLUs of the blocked sample. IfX was
> 1.9, the sample was considered positive, or else the sample
was considered negative. The value of 1.9 was recom-
mended by the manufacturer.
PCR. To prepare the sample for the PCR assay, 200 pl of
the patient sample was centrifuged for 10 min at 1,400 x g at
room temperature. The pellet was resuspended in 300 pl of
phosphate-buffered saline (PBS). Sixty microliters of this
suspension was incubated with 10 RI of proteinase K solu-
tion (Merck) at a final concentration of 25 ,ug/ml and with 10
,ul of 6% Triton X-100 for 1 h at 37°C. After heating to 1000C
for 15 min to inactivate the proteinase K, 100 pl of sterile
water distilled twice was added to the sample. Ten microli-
ters of this solution was used for the PCR assay. The PCR
assay was exactly identical to the one described previously
(11). Two sets of primers recognizing sequences of the
endogenous plasmid of C. trachomatis (20) were used. Both
generated a species-specific, 517-bp amplified product with
all known C. trachomatis serovars. One set was described
previously (5): Ti, GGACAAATCGTATCTCGG; T2, GA
AACCA ACTCTACGCTG; probe, CGCAGCGCTAGAG
GCCGGTCTATTTATGAT. The other contained the follow-
ing sequences: Ti, GCTAGAGCGGCATGCTACAT; T2,
CGCT[ GCACGAAGTACTCTG; and probe, GATTGTA
CAAGGGATCCGTAAGTTAGA. Samples were considered
positive if a PCR product was synthesized with at least one
primer set. In each run a positive control was included. The
positive control consisted of a crude phenol-chloroform
extract of a McCoy cell line infected with C. trachomatis
serovar L-2. Oligonucleotide primers and probe were syn-
thesized on an Applied Biosystems 381A DNA synthesizer.
Analysis of discordant results by PCR. For samples with
discordant results, confirmatory assays were performed (see
Table 3). A confirmatory PCR was carried out by using a
different DNA extraction procedure. Therefore, 200 Vll of the
2-SP sample was incubated with proteinase K (final concen-
tration, 0.15 mg/ml) in 0.5% sodium dodecyl sulfate for 30
min at 37°C. Nucleic acids were extracted with phenol,
phenol-chloroform-isoamyl alcohol (25:24:1; vol/vol/vol),
and chloroform-isoamyl alcohol (24:1; vol/vol). The nucleic
acids were precipitated by the addition of 0.1 volume of 3 M
sodium acetate and 3 volumes of ethanol and were stored at
-20°C overnight. After centrifugation for 10 min at 10,000 x
g, the pellet was washed once with 80% ethanol and was
dried in a vacuum exsiccator. The pellet was resuspended in
100 VI of TE buffer (10 mM Tris, 0.1 mM EDTA). Ten
microliters was used directly in the PCR assay as described
above in the section on PCR.
For analysis of discordant results obtained by CC, another
procedure was followed. PCR was performed on the wells of
the inoculated CC plates which had been stored at -20°C.
Therefore, the inoculated McCoy cells of the monolayer
were suspended in 100 pl of PBS. Then, 17.5 ,lI of proteinase
K (10 mg/ml) and 17.5 p1 of Triton X-100 (6%) were added.
After incubation at 37°C for 1 h, the sample was boiled for 10
min and was diluted with 135 p1 of twice-distilled water. Ten
microliters was used directly in the PCR assay, as described
above in the section on PCR.
Statistics. Statistical evaluation of the collected data was
performed by using Fisher's exact test. Statistical signifi-
cance was accepted at P c 0.05 (two-tailed).
RESULTS
Comparison with CC as the gold standard. A total of 1,007
patients were evaluated. The overall prevalence of chlamyd-
ial infections as measured by a positive CC result was 9.9%.
For females (n = 724) and males (n = 283), the prevalences
were 7.5 and 16.3%, respectively. Table 1 provides the
results of CV, ML, and PCR compared with the results of
CC for samples from males and females. Eight of the female
samples for CV could not be evaluated because no line
appeared in the control window. Two of these eight samples
had a positive result in CC. The overall (males and females)
sensitivity and specificity for CV compared with CC were
64.3 and 96.2%, respectively. These values for MLwere 58.0
and 99.9%, respectively, and for PCR they were 82.0 and
99.4%, respectively. Table 2 provides the sensitivities, spec-
ificities, and positive and negative predictive values of CV,
ML, and PCR in comparison with CC for samples from
males and females. The correlation between the number of
inclusions found in CC (CC score) and the sensitivities of
CV, ML, and PCR are shown in Fig. 1. The sensitivities of
J. CLIN. MICROBIOL.
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TABLE 1. CV, ML, and PCR results compared with CC results for detection of C. trachomatis in 283 males and 724 females
No. of samples
CC CV result ML result PCR result
result Males Females Males Females Males Females
+ - + - NEa + - + - + - +
+ 28 18 35 17 2 32 14 26 28 40 6 42 12
- 32 205 2 662 6 0 237 1 669 4 233 1 669
a NE, not evaluable.
CV, ML, and PCR were all significantly lower when the
number of inclusions in CC was low (scores of 1 and 2) (P <
0.0001).
Analysis of discordant results. For analysis of discordant
results between the different tests, confirmatory assays on
CC, ML, and PCR were performed. The sample for CV was
not available for further analysis. For discordant samples,
the results of initial tests with the outcomes of confirmatory
assays are given in Table 3. A new standard for comparison
of the tests was defined. If more than one test was positive,
the sample was considered true positive. If only one test was
positive and this positive result was confirmed by the con-
firmatory assay, the sample was also considered true posi-
tive. By this new standard, two false-negative and one-false
positive CC results were detected. The false-positive CC had
only one inclusion in two wells.
The final interpretations, based on the new standard, are
also given in Table 3. On the basis of these interpretations,
the sensitivities and specificities of CC, ML, PCR, and CV
were recalculated. For samples from males, the specificity of
CV was low (86.3%). All other tests had a specificity of
299.6%. The sensitivities for samples from males were as
follows: CV, 60.4%; ML, 68.8%; PCR, 87.5%; and CC,
95.8% (Fig. 2). For samples from females, all tests were
highly specific (specificities, 299.7%). The sensitivities for
samples from females were as follows: CV, 62.3%; ML,
50.9%; PCR, 79.2%; and CC, 100%. The results for females
are shown in Fig. 3.
TABLE 2. Sensitivity, specificity, predictive value of a positive
test, and predictive value of a negative test of CV, ML, and PCR
compared with CC as the gold standard for detection of
C. trachomatis in 283 males and 724 females
Percent
Test and
subject Sensitivity Specificity Predictive value Predictive value
of positive test of negative test
CV
Male 60.9 86.5 46.7 91.9
Female 67.3a 99.7a 94.6a 97.5a
ML
Male 69.9 100.0 100.0 94.4
Female 48.1 99.9 96.3 96.0
PCR
Male 87.0 98.6 90.1 97.5
Female 77.8 99.9 97.7 98.2
a Eight samples were not evaluable by CV. These samples are excluded
from these estimates of the performance of CV.
DISCUSSION
In the present study, CC was compared with three alter-
native methods for the detection of C. trachomatis in uro-
genital specimens. Swab-to-swab variability of sampling was
eliminated by performing all tests except CV on the same
sample.
Of the test methods used in the present study, CV was the
quickest and easiest test to perform. For samples from
males, both sensitivity and specificity were low (60.4 and
86.5%, respectively). To evaluate the low specificity of CV,
25 swabs without any patient material were vortexed vigor-
ously in the transport medium. CV was subsequently per-
formed. Five of the 25 swabs tested positive. An unknown
substance in the swab caused the false-positive results. The
manufacturer does not recommend the use of CV for sam-
ples from males. Our findings confirm this policy. For
samples from females, the specificity of CV was excellent
(99.7%). However, its sensitivity was low (62.3%). Other
studies (1, 8, 19, 22, 28) found higher sensitivities of CV
ranging from 79 to 95%, while specificities were consistently
lower (98.0 to 99.6%). Since CV is performed by a standard-
ized protocol, these differences in performance are most
likely caused by variations in the sensitivity of the reference
method (CC) used in the studies described here. The sensi-
tivity of our CC was probably higher than those of the CCs
used in the other studies. In our setting, the patient rooms
are next to the laboratory. Therefore, the problems associ-
ated with transport and storage conditions are confined.
Moreover, this CC method has been used frequently as a
reference method in evaluations of alternative tests for the
sensitivity
100% 96.4%
87.3%
80%
80% -
:-::;: - ~~~~69.6s 0
80%
..
........
M.%.., - ...3.S.. .-'':.......
0% 38.1%1 39.1%
27.3
21.7
20%-
0%
---
Ciearview Magic Lite PCR
FIG. 1. Relation between CC score and sensitivity of CV, ML,
and PCR. -, CC score of 1 (1 to 5 inclusions per well), X, CC
score of 2 (6 to 20 inclusions per well; 0, CC score of 3 (>20
inclusions per well).
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TABLE 3. Analysis of discordant results by confirmatory tests in males and females
No. of Test result'patieNo.s Interpretationpatients CC CCconf ML MLconf PCR PCRconf CV
Male
32 - - - - - - + False-positive CV
7 + NDC + ND + ND - False-negative CV
1 + ND - - + ND + False-negative ML
2 + ND - + + ND + False-negative ML
6 + ND - + + ND - False-negative ML and CV
2 + + - - - - + False-negative ML and PCR
1 + + + + - + - False-negative PCR and CV
1 - + + + + + - False-negative CC and CV
2 + + - - - + - False-negative ML, PCR, and CV
1 + + - - - - - False-negative ML, PCR, and CV
1 - - - - + + - False-negative CC, ML, and CV
2 - - - - + - - False-positive PCR
Female
2 - - - - - - + False-positive CV
2 + ND + ND + ND - False-negative CV
1 + ND - - + ND + False-negative ML
4 + ND - + + ND + False-negative ML
4 + ND - - + ND - False-negative ML and CV
5 + ND - + + ND - False-negative ML and CV
2 + ND - - + ND NEd False-negative ML and CV
1 + + - - - - + False-negative ML and PCR
3 + + - + - + + False-negative ML and PCR
4 + + - - - - - False-negative ML, PCR, and CV
1 + + - - - + - False-negative ML, PCR, and CV
2 + + - + - + - False-negative ML, PCR, and CV
1 - - + - - - - False-positive ML
1 - - - - + - - False-positive PCR
1 + - - - - - - False-positive CC
a Number of patients with discordant test results.
bCCconf, MLconf, and PCRconf are the confirmatory test results of CC, ML, and PCR, respectively.
ND, not done.
d NE, not evaluable.
detection of C. trachomatis (5, 6, 10, 11, 23, 26). Therefore,
a considerable amount of attention has been paid to improv-
ing the performance of this CC method over recent years.
Both the transport conditions and the performance of CC in
other settings may vary significantly. This problem of the
gold standard has been discussed previously (10).
A comparison is more reliable if an analysis of samples
with discordant results is performed. In the present study,
the CV sample was not available for further analysis. There-
fore, the error caused by swab-to-swab variability could not
be determined. To minimize the effect of swab-to-swab
variability, the sampling order was reversed. Moreover, in a
previous study (10) it was shown that swab-to-swab variabil-
ity did not have a major influence on the results.
sensitivity/specificity sensitivity/specif icity
0% ~~~~~~ ~ ~ ~ II
Clearview Magic Lite PCR Cell Culture
FIG. 2. Sensitivity (_) and specificity (5) of CV, ML, PCR,
and CC for samples from males after analysis of discordant results
by confirmatory assays.
100% -
80% -
99.7% 99.9% 99.9% 100% 99.9%
60% -
40%-
Clearview Magic Lite PCR Cell Culture
FIG. 3. Sensitivity (_) and specificity (5) of CV, ML, PCR
and CC for samples from females after analysis of discordant results
by confirmatory assays.
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ML was very specific. Only one false-positive result was
found in samples from females, and none was found in
samples from males. However, the sensitivity was low for
samples from both males (68.8%) and females (50.9%).
Forty-two ML samples were false negative. Upon retesting
of these samples, which had been stored at -70°C, 22 (55%)
samples became positive. This high number of samples with
positive ML results after freezing and thawing was evaluated
further. For this purpose, 25 CC-positive 2-SP samples,
which were collected prospectively, were tested by ML after
storage for approximately 8 weeks at both 4 and -70°C. The
samples which were stored at -70°C showed significantly
higher RLUs than the samples which were stored at 4°C
(data not shown). These findings indicate that the perfor-
mance of this highly specific technique could be improved by
using a better extraction protocol. In other studies, the
sensitivity of ML was higher. In a mixed population of 92
men and 102 women, Scieux et al. (18) found a sensitivity of
72.4% and a specificity of 97.7% for the ML compared with
CC. Neman-Simha et al. (15) compared ML with a direct
immunofluorescence technique and cell culture in 89 men
and 171 women. The sensitivity was 88.5% and the specific-
ity was 97%. These lower specificities with higher sensitiv-
ities compared with our results can also be explained by a
lower sensitivity of the CC method used in the other studies.
Another explanation for the low sensitivity of ML in our
study could be the use of another swab and transport
medium than the one supplied by the manufacturer. How-
ever, the manufacturer approved the swab and transport
medium that we used in combination with the ML. The
impact of the use of a different swab and transport medium
cannot be determined from the results of the present study.
The sensitivity of the PCR in the present evaluation was
lower than those in other studies (5, 6, 16). Furthermore, the
sensitivity of the PCR assay correlated with the number of
inclusions found in CC, as shown in Fig. 1. From this
exercise, it can be concluded that the PCR applied in the
current investigation is influenced by a limiting number of
DNA targets in the patient sample. In this respect, the
sample treatment protocol plays a crucial role. In the studies
of Claas et al. (5, 6), a phenol extraction method was used.
In addition to a purifying effect, the phenol method also has
a concentration effect. Sample volumes of 1 ml or more can
easily be concentrated to 100 ,ul, and of this concentrated
DNA, a particular volume is added to the PCR mixture.
Claas et al. (5, 6) actually applied 100 ,ul of the initial sample
volume in the final PCR. In the currently applied protocol,
the DNA was not purified at all and was actually diluted
instead of concentrated. If the dilution factor is taken into
account, only 2.2 ,ul of the original 200 ,u1 was used in the
PCR assay. The confirmatory PCR assay in the present
study used a concentrating phenol extraction step for sample
treatment. By this method, 9 of the 18 false-negative PCR
results were positive. This indicates that the sample treat-
ment method used in our study diminishes the sensitivity of
the PCR. Ossewaarde et al. (16) recently reported a PCR for
the detection of C. trachomatis that uses a simplified sample
preparation procedure in which the sample is concentrated
by centrifugation. They applied 24 ,ul of the patient sample
into the PCR. A study investigating the correlation between
the applied sample volume and the final PCR result is being
undertaken in our institute.
CC proved to be both highly specific and sensitive. Al-
though CC remains the gold standard, there is a definite need
for alternatives to this method. Both of the immunoassays
showed low sensitivities, which limits their use as diagnostic
tests. The PCR was more sensitive than the immunoassays.
The sensitivity of 87.5% for samples from males was higher
than that for samples from females (79.3%), and specificities
were excellent for samples from both groups. Nevertheless,
the performance of the PCR described here is too low to
replace CC for diagnostic purposes. Modifications in the
sample treatment should further improve the sensitivity of
the PCR.
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